Does prior use of oral anticoagulants or antiplatelets worsen 90-day mortality in patients with intracerebral hemorrhage compared to no antithrombotic use?
Both oral anticoagulants and antiplatelets are associated with worse 90-day mortality in patients who develop intracerebral hemorrhage compared to those not on antithrombotics.
In this large observational study, we found that 90-day mortality outcome was worse not only in OAC ICH but also in antiplatelet ICH, compared with patients with nonantithrombotic ICH. Antiplatelet ICH is common and is a serious condition with poor clinical outcome. Further studies are, therefore, warranted in determining the appropriate clinical management of these patients.
Apostolaki‐Hansson et al. (Wed,) studied this question.